Asterias Biotherapeutics Announces Fourth Patient Dosed in First-in-Human Clinical Study of Immunotherapy VAC2 in Non-Small Cell Lung Cancer
Two Sites in the UK Currently Enrolling Patients FREMONT, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — Asterias Biotherapeutics, Inc. (NYSE […]